TRIMARCHI THOMAS (President and CFO) sold 3.7% of their position (13.65K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $888.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/19/2026ACC: 0001470831-26-000473
Officer· President and CFO
Since Feb 2026
-36.43K
Net shares
Net seller
$2.39M
Total sold
2
Open market trades
0B · 2S
3
Total transactions
36.43K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−22.78K
Price / share
$66.13
Trade value
$1.51M
% of position
5.8%
5/16/2026
395.63K→372.85K
Common Stock
Direct
Shares
−10.46K
Price / share
$64.82
Trade value
$677.71K
% of position
2.8%
5/18/2026
372.85K→362.39K
Common Stock
Direct
Shares
−3.19K
Price / share
$65.95
Trade value
$210.71K
% of position
0.9%
5/18/2026
362.39K→359.19K
Total
Net shares
−36.43K
Net value
-$2.39M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/16/2026 | F · Tax Withholding | −22.78K | $66.13 | $1.51M | 5.8% | 395.63K | 372.85K |
| Common Stock Direct | 5/18/2026 | S · Sale | −10.46K | $64.82 | $677.71K | 2.8% | 372.85K | 362.39K |
| Common Stock Direct | 5/18/2026 | S · Sale | −3.19K | $65.95 | $210.71K | 0.9% | 362.39K | 359.19K |
| Total | −36.43K | -$2.39M | ||||||
Derivative Transactions0
No derivative transactions reported